These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 22784431)

  • 1. Indole-3-carbinol blocks platelet-derived growth factor-stimulated vascular smooth muscle cell function and reduces neointima formation in vivo.
    Guan H; Chen C; Zhu L; Cui C; Guo Y; Fu M; Wang L; Tang Q
    J Nutr Biochem; 2013 Jan; 24(1):62-9. PubMed ID: 22784431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury.
    Guan H; Zhu L; Fu M; Yang D; Tian S; Guo Y; Cui C; Wang L; Jiang H
    PLoS One; 2012; 7(4):e34957. PubMed ID: 22506059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apigenin attenuates neointima formation via suppression of vascular smooth muscle cell phenotypic transformation.
    Guan H; Gao L; Zhu L; Yan L; Fu M; Chen C; Dong X; Wang L; Huang K; Jiang H
    J Cell Biochem; 2012 Apr; 113(4):1198-207. PubMed ID: 22095643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound K, an intestinal metabolite of ginsenosides, inhibits PDGF-BB-induced VSMC proliferation and migration through G1 arrest and attenuates neointimal hyperplasia after arterial injury.
    Park ES; Lee KP; Jung SH; Lee DY; Won KJ; Yun YP; Kim B
    Atherosclerosis; 2013 May; 228(1):53-60. PubMed ID: 23473423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia.
    Dong LH; Wen JK; Miao SB; Jia Z; Hu HJ; Sun RH; Wu Y; Han M
    Cell Res; 2010 Nov; 20(11):1252-62. PubMed ID: 20661261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirubin-3'-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo.
    Schwaiberger AV; Heiss EH; Cabaravdic M; Oberan T; Zaujec J; Schachner D; Uhrin P; Atanasov AG; Breuss JM; Binder BR; Dirsch VM
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2475-81. PubMed ID: 20847306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury.
    Yan G; Wang Q; Hu S; Wang D; Qiao Y; Ma G; Tang C; Gu Y
    Int J Mol Med; 2015 Oct; 36(4):1001-11. PubMed ID: 26311435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salidroside blocks the proliferation of pulmonary artery smooth muscle cells induced by platelet‑derived growth factor‑BB.
    Chen C; Tang Y; Deng W; Huang C; Wu T
    Mol Med Rep; 2014 Aug; 10(2):917-22. PubMed ID: 24840151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of 2,3,4',5-tetrahydroxystilbene-2-0-β-D glucoside on neointima formation in a rat artery balloon injury model and its possible mechanisms.
    Xu XL; Ling DY; Zhu QY; Fan WJ; Zhang W
    Eur J Pharmacol; 2013 Jan; 698(1-3):370-8. PubMed ID: 23178522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phloretin Inhibits Platelet-derived Growth Factor-BB-induced Rat Aortic Smooth Muscle Cell Proliferation, Migration, and Neointimal Formation After Carotid Injury.
    Wang D; Wang Q; Yan G; Qiao Y; Tang C
    J Cardiovasc Pharmacol; 2015 May; 65(5):444-55. PubMed ID: 25945863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piperine inhibits platelet-derived growth factor-BB-induced proliferation and migration in vascular smooth muscle cells.
    Lee KP; Lee K; Park WH; Kim H; Hong H
    J Med Food; 2015 Feb; 18(2):208-15. PubMed ID: 25384161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation.
    Zhu LH; Huang L; Zhang X; Zhang P; Zhang SM; Guan H; Zhang Y; Zhu XY; Tian S; Deng K; Li H
    Clin Sci (Lond); 2015 Jul; 129(2):129-45. PubMed ID: 25751394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin Calcium Inhibits PDGF-ββ-Induced Proliferation and Migration of VSMCs Through the G0/G1 Cell Cycle Arrest and Suppression of Activated PDGFRβ-PI3K-Akt Signaling Cascade.
    Chen S; Dong S; Li Z; Guo X; Zhang N; Yu B; Sun Y
    Cell Physiol Biochem; 2017; 44(1):215-228. PubMed ID: 29131001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells.
    Lee KP; Sudjarwo GW; Jung SH; Lee D; Lee DY; Lee GB; Baek S; Kim DY; Lee HM; Kim B; Kwon SC; Won KJ
    Atherosclerosis; 2015 Jun; 240(2):367-73. PubMed ID: 25875388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
    Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
    Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnolol attenuates neointima formation by inducing cell cycle arrest via inhibition of ERK1/2 and NF-kappaB activation in vascular smooth muscle cells.
    Karki R; Ho OM; Kim DW
    Biochim Biophys Acta; 2013 Mar; 1830(3):2619-28. PubMed ID: 23274740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tangeretin, a citrus flavonoid, inhibits PGDF-BB-induced proliferation and migration of aortic smooth muscle cells by blocking AKT activation.
    Seo J; Lee HS; Ryoo S; Seo JH; Min BS; Lee JH
    Eur J Pharmacol; 2011 Dec; 673(1-3):56-64. PubMed ID: 22040922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apamin inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration through suppressions of activated Akt and Erk signaling pathway.
    Kim JY; Kim KH; Lee WR; An HJ; Lee SJ; Han SM; Lee KG; Park YY; Kim KS; Lee YS; Park KK
    Vascul Pharmacol; 2015 Jul; 70():8-14. PubMed ID: 25737404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1/2 signaling.
    Wu JR; Liou SF; Lin SW; Chai CY; Dai ZK; Liang JC; Chen IJ; Yeh JL
    Pharmacol Res; 2009 Jan; 59(1):48-56. PubMed ID: 18973813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.